Logo image of RVMD

REVOLUTION MEDICINES INC (RVMD) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:RVMD - US76155X1000 - Common Stock

79.64 USD
+1.16 (+1.48%)
Last: 12/5/2025, 8:00:01 PM
79 USD
-0.64 (-0.8%)
After Hours: 12/5/2025, 8:00:01 PM
Fundamental Rating

2

Overall RVMD gets a fundamental rating of 2 out of 10. We evaluated RVMD against 531 industry peers in the Biotechnology industry. While RVMD seems to be doing ok healthwise, there are quite some concerns on its profitability. RVMD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year RVMD has reported negative net income.
RVMD had a negative operating cash flow in the past year.
In the past 5 years RVMD always reported negative net income.
RVMD had a negative operating cash flow in each of the past 5 years.
RVMD Yearly Net Income VS EBIT VS OCF VS FCFRVMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

With a decent Return On Assets value of -26.65%, RVMD is doing good in the industry, outperforming 70.06% of the companies in the same industry.
RVMD's Return On Equity of -37.58% is fine compared to the rest of the industry. RVMD outperforms 71.75% of its industry peers.
Industry RankSector Rank
ROA -26.65%
ROE -37.58%
ROIC N/A
ROA(3y)-25.08%
ROA(5y)-24.01%
ROE(3y)-28.89%
ROE(5y)-28.2%
ROIC(3y)N/A
ROIC(5y)N/A
RVMD Yearly ROA, ROE, ROICRVMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RVMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RVMD Yearly Profit, Operating, Gross MarginsRVMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -1K -2K -3K -4K

More info and screens

5

2. Health

2.1 Basic Checks

RVMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RVMD has been increased compared to 1 year ago.
The number of shares outstanding for RVMD has been increased compared to 5 years ago.
There is no outstanding debt for RVMD. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
RVMD Yearly Shares OutstandingRVMD Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
RVMD Yearly Total Debt VS Total AssetsRVMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

RVMD has an Altman-Z score of 12.46. This indicates that RVMD is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of RVMD (12.46) is better than 83.62% of its industry peers.
RVMD has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.16, RVMD is not doing good in the industry: 65.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Altman-Z 12.46
ROIC/WACCN/A
WACC8.78%
RVMD Yearly LT Debt VS Equity VS FCFRVMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 8.05 indicates that RVMD has no problem at all paying its short term obligations.
RVMD has a Current ratio of 8.05. This is in the better half of the industry: RVMD outperforms 74.39% of its industry peers.
A Quick Ratio of 8.05 indicates that RVMD has no problem at all paying its short term obligations.
With a decent Quick ratio value of 8.05, RVMD is doing good in the industry, outperforming 74.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.05
Quick Ratio 8.05
RVMD Yearly Current Assets VS Current LiabilitesRVMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

3

3. Growth

3.1 Past

RVMD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -44.01%.
Looking at the last year, RVMD shows a very negative growth in Revenue. The Revenue has decreased by -100.00% in the last year.
EPS 1Y (TTM)-44.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.28%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

The Earnings Per Share is expected to grow by 14.00% on average over the next years. This is quite good.
RVMD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 454.63% yearly.
EPS Next Y-59.96%
EPS Next 2Y-35.33%
EPS Next 3Y-18.97%
EPS Next 5Y14%
Revenue Next Year1279.08%
Revenue Next 2Y959.84%
Revenue Next 3Y770.59%
Revenue Next 5Y454.63%

3.3 Evolution

RVMD Yearly Revenue VS EstimatesRVMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B
RVMD Yearly EPS VS EstimatesRVMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 5 -5 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

RVMD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RVMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RVMD Price Earnings VS Forward Price EarningsRVMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RVMD Per share dataRVMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

A cheap valuation may be justified as RVMD's earnings are expected to decrease with -18.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-35.33%
EPS Next 3Y-18.97%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RVMD!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

REVOLUTION MEDICINES INC

NASDAQ:RVMD (12/5/2025, 8:00:01 PM)

After market: 79 -0.64 (-0.8%)

79.64

+1.16 (+1.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-24 2026-02-24/amc
Inst Owners100.6%
Inst Owner Change1.75%
Ins Owners1.87%
Ins Owner Change-1.38%
Market Cap15.40B
Revenue(TTM)N/A
Net Income(TTM)-600.09M
Analysts87.41
Price Target81.55 (2.4%)
Short Float %9.39%
Short Ratio7.82
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-12.02%
Min EPS beat(2)-12.79%
Max EPS beat(2)-11.24%
EPS beat(4)0
Avg EPS beat(4)-9.21%
Min EPS beat(4)-12.79%
Max EPS beat(4)-1.54%
EPS beat(8)1
Avg EPS beat(8)-7.65%
EPS beat(12)4
Avg EPS beat(12)-2.45%
EPS beat(16)6
Avg EPS beat(16)-2.06%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.09%
PT rev (3m)10.17%
EPS NQ rev (1m)-2.07%
EPS NQ rev (3m)-5.48%
EPS NY rev (1m)-4.37%
EPS NY rev (3m)-6.89%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)25.53%
Revenue NY rev (1m)6.08%
Revenue NY rev (3m)-34.72%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 9.64
P/tB 10.09
EV/EBITDA N/A
EPS(TTM)-5.17
EYN/A
EPS(NY)-6.54
Fwd EYN/A
FCF(TTM)-4.02
FCFYN/A
OCF(TTM)-3.94
OCFYN/A
SpS0
BVpS8.26
TBVpS7.9
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -26.65%
ROE -37.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-25.08%
ROA(5y)-24.01%
ROE(3y)-28.89%
ROE(5y)-28.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.16
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 277.69%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.05
Quick Ratio 8.05
Altman-Z 12.46
F-Score1
WACC8.78%
ROIC/WACCN/A
Cap/Depr(3y)158.77%
Cap/Depr(5y)142.66%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-44.01%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-71.28%
EPS Next Y-59.96%
EPS Next 2Y-35.33%
EPS Next 3Y-18.97%
EPS Next 5Y14%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year1279.08%
Revenue Next 2Y959.84%
Revenue Next 3Y770.59%
Revenue Next 5Y454.63%
EBIT growth 1Y-41.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-68.61%
EBIT Next 3Y-28.97%
EBIT Next 5Y7.47%
FCF growth 1Y-158.95%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-161.07%
OCF growth 3YN/A
OCF growth 5YN/A

REVOLUTION MEDICINES INC / RVMD FAQ

What is the ChartMill fundamental rating of REVOLUTION MEDICINES INC (RVMD) stock?

ChartMill assigns a fundamental rating of 2 / 10 to RVMD.


Can you provide the valuation status for REVOLUTION MEDICINES INC?

ChartMill assigns a valuation rating of 0 / 10 to REVOLUTION MEDICINES INC (RVMD). This can be considered as Overvalued.


How profitable is REVOLUTION MEDICINES INC (RVMD) stock?

REVOLUTION MEDICINES INC (RVMD) has a profitability rating of 1 / 10.


Can you provide the financial health for RVMD stock?

The financial health rating of REVOLUTION MEDICINES INC (RVMD) is 5 / 10.


Can you provide the expected EPS growth for RVMD stock?

The Earnings per Share (EPS) of REVOLUTION MEDICINES INC (RVMD) is expected to decline by -59.96% in the next year.